Brayden D. Hamill

Statistics

Publications

Citations

H-Index

Active since

2014

Affiliations

University of Colorado Anschutz Medical Campus(Current)

University of Montana

Brayden D. Hamill is an author at University of Colorado Anschutz Medical Campus specializing in dna topoisomerase ii inhibition, molecular oncology, and medicine.

Publications per year

2014–2019

Publications

Drug Design Targeting T-Cell Factor-Driven Epithelial–Mesenchymal Transition as a Therapeutic Strategy for Colorectal Cancer

Adedoyin D. Abraham, Hector Esquer, Qiong Zhou et al. · Journal of Medicinal Chemistry · 2019 · 18 citations · Full text

Medicine, Oncology, Pharmacology +17

An Improved High Yield Total Synthesis and Cytotoxicity Study of the Marine Alkaloid Neoamphimedine: An ATP-Competitive Inhibitor of Topoisomerase IIα and Potent Anticancer Agent

Linfeng Li, Adedoyin D. Abraham, Qiong Zhou et al. · Marine Drugs · 2014 · 13 citations · Full text

Medicine, Medicinal Chemistry, Oncology +13

1–2 of 2